IDT partners with some of the most comprehensive genomic sequencing servicers in the world. These companies are aligned in our commitment to collaboration, and we are aligned in our resolve to break down research barriers. Whether you’re focused on whole genome sequencing or custom panels, our partners have you covered.
IDT continues to bring you quality data and services for researchers using cutting edge solutions. The IDT Align Preferred Sequencing Provider Program minimizes your search time to find the sequencing provider tailored to your research. Sequencing options include whole genome sequencing, whole exome sequencing, targeted sequencing, custom panels, single cell sequencing, for discovery and preclinical, translational and clinical, and quality control.
The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics.
MGI aims to improve the human condition by producing, studying and interpreting high-quality genome-based data that drives biological discoveries that range from the bench to the hospital bedside. MGI values the open sharing of information and ideas and encourages collaboration while also engaging the next generation of scientists through educational outreach efforts.
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world.
Novogene utilizes scientific excellence, a commitment to customer service, and unsurpassed data quality to help our clients realize their research goals. The company has become a global leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 29 NGS-related patents, as well as publishing of over 4,920 customer research papers, often in well-respected publications such as Nature and Science.
Predicine is a California-based molecular insights company that has developed an NGS liquid biopsy platform to analyze cfDNA and cfRNA genomic alterations in blood and urine for research. Predicine has launched its 152-gene PredicineCARE, 600-gene PredicineATLAS, and PredicineALERT MRD liquid biopsy tests for identifying cancer variants (TMB, MSI, HRD, and gene deletion), researching drug efficacy and MRD. Partnering with leading biopharmas, Predicine provides harmonized liquid biopsy tests and CDx development to support global clinical trials in the U.S., Europe, and the Asia-Pacific region, including China.
Geneseeq Technology is a research-driven company providing cutting-edge genomic sequencing to accelerate precision cancer care. Their molecular profiling informs targeted therapy and immunotherapy options in solid and blood tumors with pan-cancer panels analyzing 400+ genes and cancer-specific gene panels. The company’s high-quality genomic data and fast turnaround times also fuel translational research activities in biomarker development. In addition, they provide NGS sequencing for academic and clinical research.
Psomagen, formerly Macrogen USA, is a US-based, CLIA certified and CAP accredited genomic services company. The company delivers genetic sequencing and bioinformatics for clinical and academic research.
The company’s mission is to positively impact the health of humanity through Sanger sequencing, next generation sequencing, and microarray gene analysis services. The company is networked with Macrogen’s worldwide headquarters, which means their capabilities and expertise stretch across a diverse set of labs around the world.
The Munich Leukemia Laboratory (MLL) is a leading European-based institution for leukemia diagnostics and research. The expertise embedded within the company, along with its excellent quality assurance and turnaround times, position hematological diagnostics and research teams for success.
MLL offers a wide range of genomic services, providing researchers a comprehensive picture of existing and novel illnesses within patients.
AIT is Austria’s largest applied non-university research institute. AIT’s Molecular Diagnostics unit focuses on non- and minimally invasive methods to provide contract research services for transcriptomics, epigenetics, and immunomics-type projects. Their research expertise ranges from biomarker discovery to assay design and bioinformatics. AIT offers additional services such as tailored analysis and multiplexed testing from minimal amounts of research specimen using well-established workflows. AIT enables customers to focus on their core business, while Europe’s most competent brains work to develop the tools and technologies of tomorrow so that the solutions for the day after tomorrow can be implemented.Click Here
Admera Health is a provider of advanced genomic and bioinformatic support that leverages next generation sequencing expertise for researchers in academia and biopharmaceutical companies. Its team offers a comprehensive suite of genomic services, including, WGS, RNA-seq, WGBS, single-cell RNA-seq, and WES, as well as tailored solutions. All samples are managed with exceptional attention and upheld to the highest quality standards, and are processed in a CLIA/CLEP-certified and CAP-accredited environment. Admera Health is committed to utilizing cutting-edge technology in research to deliver comprehensive data. The team at Admera Health uses state-of-the-art platforms and tools for genomic sequencing, bioinformatics analysis, and data interpretation to provide the most accurate and reliable results possible.Click Here
Sistemas Genómicos is the first and largest Spanish company specialized in genetic sequencing with almost two decades of experience in the field of molecular biology and genetics, specializing in techniques aimed at the fields of health, agri-food, and research.
In addition to a strong background in agricultural genomics, the company has developed advanced genetics and bioinformatics technologies for personalized biomedical research solutions. Sistemas Genómicos is a leader in Spain and internationally in research and development for genomic research services.
Catalytic Data Science is a leading provider of discovery informatics solutions designed for both bench researchers and bioinformatics specialists.
The Catalytic platform delivers a comprehensive suite of on-demand multi-omics analysis pipelines used today by researchers at large pharmaceutical companies, early-stage biopharmaceutical companies, and academic institutions.
Catalytic’s mission is to accelerate innovation and make achieving scientific milestones more predictable through state-of-the-art informatics.
*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.